| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 04/20/1989 | WO1989003393A1 Vasoactive peptides |
| 04/20/1989 | WO1989003392A1 Polypeptides with type iv collagen activity |
| 04/20/1989 | WO1989003391A1 Oligopeptides and their use for diagnostic and vaccination purposes for aids and arc |
| 04/20/1989 | WO1989003225A1 Purification of monomeric interferon |
| 04/20/1989 | WO1989003222A1 Soluble human cd4 fragments and uses therefor |
| 04/20/1989 | WO1989003221A1 Antisyncytial agent |
| 04/20/1989 | WO1989003041A3 Tridentate conjugate and method of use thereof |
| 04/20/1989 | WO1989001783A3 Recombinant antibody and method |
| 04/19/1989 | EP0312358A2 Method for promoting intramolecular disulfide bond formation in recombinant proteins contained in a denaturant solution |
| 04/19/1989 | EP0312291A2 Di-or tripeptide renin inhibitors containing lactam conformational restriction in ACHPA |
| 04/19/1989 | EP0312283A2 Di-or tripeptide renin inhibitors containing lactam conformational restrictions in ACHPA |
| 04/19/1989 | EP0312173A2 Particle-stabilized epitopes for standardization and control of immunoassays |
| 04/19/1989 | EP0312164A1 Purification of recombinant epstein-barr virus antigens from vero cells, yeast cells or L cells |
| 04/19/1989 | EP0312159A2 Method for producing hepatitis B virus proteins in yeast |
| 04/19/1989 | EP0312158A2 Tetrapeptide renin inhibitors having novel c-terminal amino acid amide |
| 04/19/1989 | EP0312157A2 Tetrapeptide renin inhibitors having a novel c-terminal amino acid |
| 04/19/1989 | EP0312127A2 Glycosylated insulin derivatives |
| 04/19/1989 | EP0311950A2 Procedure for preparing a sterile plasme protein solution, which contains fibrinogen and coagulation factor XIII |
| 04/19/1989 | EP0311675A1 Immunotherapeutic methods and compositions |
| 04/19/1989 | EP0192677B1 Processes for recovery of products from waxy barley |
| 04/18/1989 | US4822894 Pure cis enantiomers of fused pyrrole ring carboxylates |
| 04/18/1989 | US4822872 Preferential adsorption of impurities on water insoluble carrier with amine or aldehyde ligands |
| 04/18/1989 | US4822776 Lipoprotein lipase suppression by endotoxin-induced mediator (shock assay) |
| 04/18/1989 | US4822774 Bronchodilator agent and hypotensive agent |
| 04/18/1989 | US4822735 Mutants |
| 04/18/1989 | US4822612 Anticancer agent |
| 04/18/1989 | US4822606 Immunosuppressive synthetic peptides and analogs thereof based on retroviral envelope sequences |
| 04/18/1989 | US4822535 Method for producing small, spherical polymer particles |
| 04/18/1989 | CA1252948A1 Process for purifying proteins |
| 04/18/1989 | CA1252744A1 Ultrapurification of factor ix and other vitamin k- dependent proteins |
| 04/18/1989 | CA1252720A1 Vaccine for cytomegalovirus |
| 04/18/1989 | CA1252719A1 METHOD FOR THE PREPARATION OF CONJUGATES OF ADENINE-9- .beta.-ARABINOFURANOSIDE 5' MONOPHOSPHATE WITH LACTOSAMINATED HUMAN ALBUMIN, THE CONJUGATES OBTAINED AND THERAPEUTICALLY ACTIVE COMPOSITION CONTAINING THEM |
| 04/18/1989 | CA1252718A1 Method of treating cerebral ischemia |
| 04/18/1989 | CA1252715A1 Diagnostic assay for inhibitor of tissue-type and urokinase-type plasminogen activator |
| 04/12/1989 | EP0311438A2 Antigen capable of binding to cancer cells |
| 04/12/1989 | EP0311283A2 Process for obtaining concentrates having a high alpha-lactalbumin content from whey |
| 04/12/1989 | EP0311228A2 Recombinant polypeptides and their uses, including assay for AIDS virus |
| 04/12/1989 | EP0311219A1 Oligopeptides and their use for diagnostic and vaccination purposes for AIDS and ARC |
| 04/12/1989 | EP0311193A2 Antifungal fermentation product |
| 04/12/1989 | EP0310887A2 Vasoconstrictor peptide |
| 04/12/1989 | EP0310719A1 Method for purification of antibodies |
| 04/12/1989 | CN1032367A Dna construction with preceding sequence of kluyveromyces x-factor directing heterologous polypeptide excretion |
| 04/11/1989 | US4820804 Analogs of [1,7-di-alanine, des-19-leucine]calcitonin |
| 04/11/1989 | US4820729 Hypotensive agents |
| 04/11/1989 | US4820691 Hypotensive agents |
| 04/11/1989 | US4820689 Pharmaceutical composition containing a glycoprotein |
| 04/11/1989 | US4820642 Over production of beta-lactamase by dna; vaccine against hepatitis b |
| 04/11/1989 | US4820641 Monoclonal antibody capable of specifically distinguishing human hepato-carcinoma cells |
| 04/11/1989 | US4820639 Process for enhancing translational efficiency of eukaryotic mRNA |
| 04/11/1989 | US4820638 Novel alpha interferon species produced by recombinant means |
| 04/11/1989 | US4820633 Process for production of an immune reactive, porous carrier material for heterogeneous immunological analysis |
| 04/11/1989 | US4820631 Kits for cancer detection |
| 04/06/1989 | WO1989003041A2 Tridentate conjugate and method of use thereof |
| 04/06/1989 | WO1989002935A1 Respiratory syncytial virus: vaccines and diagnostic assays |
| 04/06/1989 | WO1989002924A1 Vaccines for malaria |
| 04/06/1989 | WO1989002922A1 Adheson variants |
| 04/06/1989 | WO1989002915A1 Human cell lines of epithelial lung adenocarcinoma origin, human proteins and methods |
| 04/06/1989 | WO1989002898A1 Reagents and probes for distinguishing and isolating different gtp-binding proteins |
| 04/06/1989 | WO1989002897A1 Therapeutic peptides |
| 04/06/1989 | WO1989002751A1 Pharmaceutical compositions of recombinant interleukin-2 and formulation processes |
| 04/06/1989 | WO1989002750A1 Pharmaceutical compositions of recombinant beta-interferon and formulation processes |
| 04/06/1989 | WO1989002746A1 Uses of recombinant colony stimulating factor-1 |
| 04/06/1989 | WO1989002744A1 Synergistic antifungal protein and compositions containing same |
| 04/06/1989 | WO1989001490A3 Biologically active molecules |
| 04/05/1989 | EP0310361A2 Tridentate conjugate and method of use thereof |
| 04/05/1989 | EP0310288A2 Improved ovulation treatment |
| 04/05/1989 | EP0310238A2 New physiologically active substances, probestin and prostatin and production thereof |
| 04/05/1989 | EP0310178A1 Recovery of pres2+S antigen |
| 04/05/1989 | EP0310137A2 BAR1 secretion signal |
| 04/05/1989 | EP0310136A2 Macrophage-derived inflammatory mediator (MIP-1alpha and MIP-1beta) |
| 04/05/1989 | EP0310056A2 Thymic stroma-derived T cell growth factor and process for its production |
| 04/05/1989 | EP0310030A1 Cloning of DNA encoding transcription factor S-11 and utilization of the DNA |
| 04/05/1989 | EP0310015A2 Renin-inhibiting dipeptides, process for their preparation, medicines containing them and their use |
| 04/05/1989 | EP0309841A2 Amino acid derivatives |
| 04/05/1989 | EP0309787A2 Process for producing a highly purified, virus-free and biologically active transferrin preparation |
| 04/05/1989 | EP0309746A1 Antimalaria vaccines |
| 04/05/1989 | EP0309569A1 Production of purified, biologically active, bacterially produced recombinant human csf-1 |
| 04/05/1989 | EP0309559A1 Transgenic animals. |
| 04/05/1989 | EP0309555A1 Immunogenic polypeptide and method for purifying it |
| 04/05/1989 | EP0309548A1 Human tissue factor related dna segments, polypeptides and antibodies |
| 04/05/1989 | EP0168478B1 Cancer chemotherapeutic cyclic and acyclic disulfonic ester compounds, method of use therefor, and intermediates |
| 04/04/1989 | US4818763 Immunostimulants |
| 04/04/1989 | US4818749 Carboxyalkyl dipeptides and medical use thereof in treating hypertension and congestive heart failure |
| 04/04/1989 | US4818698 Polypeptides and preparation process thereof |
| 04/04/1989 | US4818696 Rhizobium japonicum symbiosis gene transfer |
| 04/04/1989 | US4818694 Production of herpes simplex viral protein |
| 04/04/1989 | US4818688 Assays for antibody to hepatitis B core antigen |
| 04/04/1989 | US4818684 Immunoassay; binding antibody to steroid complex |
| 04/04/1989 | US4818527 T cell epitopes of the hepatitis B virus nucleocapsid protein |
| 04/04/1989 | CA1252046A1 Methods for oncogenic detection |
| 04/04/1989 | CA1252042A1 Infectious bursal disease virus vaccine |
| 03/30/1989 | DE3731875A1 Gentechnische herstellung von neukombinierten plasmiden fuer die produktion von humanem adrenocorticotropen horman (acth) und davon abgeleiteten derivaten durch enzymatische spaltung primaer synthetisierter fusionsproteine Genetic manufacture of recombined plasmids for the production of human adrenocorticotropic horman (acth) and derived by enzymatic cleavage derivatives synthesized fusion proteins primaer |
| 03/30/1989 | DE3731874A1 Verfahren zur herstellung von peptiden durch spezifische spaltung von gentechnisch gewonnenen fusionsproteinen mit collagenasen Process for the preparation of peptides by specific cleavage of fusion proteins with genetically acquired collage noses |
| 03/29/1989 | EP0309324A1 Process for the preparation of N-alkylated amino acids and their esters, use in the synthesis of carboxyalkyl dipeptides |
| 03/29/1989 | EP0309297A2 Therapeutic peptides |
| 03/29/1989 | EP0309241A2 Inductive collagen-based bone repair preparations |
| 03/29/1989 | EP0309237A1 A transient expression system for producing recombinant protein |
| 03/29/1989 | EP0309145A1 Bacteriophage-resistant strain of Bacillus Thuringiensis Var. San Diego |
| 03/29/1989 | EP0309120A2 Atrial hypotensive peptide |
| 03/29/1989 | EP0309100A2 Use of amylin or CGRP for the treatment of diabetes mellitus |